Chitosan-coated alginate microspheres for embolization and/or chemoembolization: In vivo studies

Autor: Eroglu, M., Kurşaklioglu, H., Misirli, Y., Iyisoy, A., Acar, A., Işin Dogan, A., Denkbaş, E.B.

In this study, chitosan-coated alginate microspheres were prepared by the ionic complexation of alginate and chitosan biopolymers to use in embolization and/or chemoembolization studies. Biopolymeric microspheres were prepared by the ionic gelation t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10007::e6a72c9de508308732fbe20b1670b5a7
https://hdl.handle.net/20.500.11831/1354

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.

Autor: van Egmond S; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Vliet ED; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Wakkee M; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hollestein LM; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., Pouwels XGLV; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Koffijberg H; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Misirli Y; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., Bakkum RSLA; Department of Dermatology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands., Bastiaens MT; Department of Dermatology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Kukutsch NA; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands., Oosting AJ; Department of Dermatology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands., Plasmeijer EI; Department of Dermatology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Rengen A; Department of Dermatology, Mohs Klinieken, Dordrecht, The Netherlands., de Roos KP; Department of Dermatology, DermaPark, Uden, The Netherlands., Nijsten TEC; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Vries E; Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogota, Colombia., de Bekker-Grob EW; Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.

Publikováno v: PloS one [PLoS One] 2022 Jan 24; Vol. 17 (1), pp. e0260978. Date of Electronic Publication: 2022 Jan 24 (Print Publication: 2022).